Study summary · 2024 · Evidence review

Home BP-guided treatment in US telemedicine trials

Home BP-guided treatment improved blood-pressure control relative to clinic-based care.

Summary by Vironix Health · Source review: November 11, 2026
How we select and interpret evidence

Original publication

Self-Measured Blood Pressure-Guided Pharmacotherapy: A Systematic Review and Meta-Analysis of United States-Based Telemedicine Trials

Sameer Acharya; Gagan Neupane; Austin Seals; Madhav Kc; Dean Giustini; Sharan Sharma; Yhenneko J Taylor; Deepak Palakshappa; Jeff D Williamson; Justin B Moore; Hayden B Bosworth; Yashashwi Pokharel

Cayuga Medical Center; Atrium Health/Wake Forest; Florida Atlantic; Yale; University of British Columbia; SCL Health; Duke University

Hypertension · Online: · Issue: March 2024

Final journal citation; full text checked in PMC and the publisher PDF held by Duke. · Full text consulted.

What was studied

Design
Evidence review
Population
Adults in US hypertension trials
Sample
13 trials/5,330 participants for systolic BP; 7 trials/3,766 for BP control
Intervention
Self-measured BP guiding medication treatment, with variable support
Comparator
Clinic-based care
Follow-up
At least 6 months
Review search cutoff
2023-07-07
Setting
United States

Methods

Random-effects meta-analysis of US randomized trials with subgroup comparisons.

Findings

Systolic BP was lower by 7.3 mmHg (95% CI 5.2–9.4 lower). BP control improved by 10.1 percentage points (95% CI 0.4–19.9).

Limitations

Some trials transmitted readings by mail. Care-team subgroup differences are associations, not randomized component effects; interventions and populations varied.

What this means for care delivery

The evidence supports measurement linked to medication management, not device distribution alone.